We are live on ! Find out more
NXTM

NxStage Medical Inc.
NXTM

Delisted

NXTM was delisted on the 21st of February, 2019.

Back to rankings

114 hedge funds and large institutions have $541M invested in NxStage Medical Inc. in 2013 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 45 increasing their positions, 35 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

964% more call options, than puts

Call options by funds: $266K | Put options by funds: $25K

29% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 35

1% less funds holding

Funds holding: 115 → 114 (-1)

5% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 20

23% less capital invested

Capital invested by funds: $705M → $541M (-$164M)

40% less funds holding in top 10

Funds holding in top 10: 5 → 3 (-2)

Holders
114
Holders Change
-1
Holders Change %
-0.87%
% of All Funds
3.31%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.09%
New
19
Increased
45
Reduced
35
Closed
20
Calls
$266K
Puts
$25K
Net Calls
+$241K
Net Calls Change
-$335K

Top Buyers

Rank Fund Capital Flow
1
OIM
Oracle Investment Management
Connecticut
+$10.8M
2
TCM
Tamarack Capital Management
California
+$9.73M
3
CCM
Camber Capital Management
Massachusetts
+$9.31M
4
RG
Redmile Group
California
+$7.84M
5
DM
Deerfield Management
New York
+$6.17M

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$21.6M
2
Ameriprise
Ameriprise
Minnesota
-$14.7M
3
FAM
Fred Alger Management
New York
-$13.9M
4
CM
Castleark Management
Illinois
-$6.8M
5
CS
Credit Suisse
Switzerland
-$5.32M
Name Holding Trade Value Shares
Change 		Change in
Stake
RG
26
Redmile Group
California
$6.91M +$7.84M +690,770 New
AGA
27
Altrinsic Global Advisors
Connecticut
$6.66M +$1.7M +150,000 +29%
CCP
28
Clough Capital Partners
Massachusetts
$6.59M -$1.05M -92,387 -12%
BC
29
Broadfin Capital
New York
$5.43M +$6.17M +543,466 New
BCM
30
BBT Capital Management
Texas
$4.02M +$3.37M +297,000 +283%
WMSA
31
Weiss Multi-Strategy Advisers
New York
$3.95M – – –
DCM
32
DAFNA Capital Management
California
$3.84M +$1.5M +132,500 +53%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$2.98M -$38.6K -3,397 -1%
Geode Capital Management
34
Geode Capital Management
Massachusetts
$2.77M +$305K +26,869 +11%
State of Wisconsin Investment Board
35
State of Wisconsin Investment Board
Wisconsin
$2.53M – – –
TCIM
36
TIAA CREF Investment Management
New York
$2.44M -$8.35K -736 -0.3%
Citadel Advisors
37
Citadel Advisors
Florida
$2.2M +$1.72M +151,511 +220%
FWIA
38
Fort Washington Investment Advisors
Ohio
$2.19M -$552K -48,673 -18%
HPCM
39
High Pointe Capital Management
Illinois
$2.14M +$1.16M +102,280 +92%
ERSOT
40
Employees Retirement System of Texas
Texas
$1.98M – – –
BIM
41
BlackRock Investment Management
Delaware
$1.64M -$57.9K -5,100 -3%
Charles Schwab
42
Charles Schwab
California
$1.56M +$275K +24,211 +18%
CA
43
Continental Advisors
Utah
$1.51M +$682K +60,100 +66%
KCM
44
Kennedy Capital Management
Missouri
$1.5M -$35.3K -3,110 -2%
N
45
Nuveen
North Carolina
$1.48M -$584K -51,429 -26%
MAA
46
Managed Account Advisors
New Jersey
$1.43M -$705K -62,105 -30%
GTC
47
Ghost Tree Capital
New York
$1.25M +$1.42M +125,000 New
SCM
48
Sterling Capital Management
North Carolina
$1.23M +$1.4M +123,072 New
AllianceBernstein
49
AllianceBernstein
Tennessee
$1.2M – – –
NIM
50
Needham Investment Management
New York
$1.2M +$568K +50,000 +71%
1
2
3 4 5

NXTM Hedge Fund Activity: Q4 2013 in Review

114 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q4 2013, worth a combined $541M — down 23% from $705M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of NXTM and 19 opened new positions — a net loss of 1 holder — while 35 trimmed existing stakes and 45 added.

The largest buyer was Oracle Investment Management, adding an estimated $10.8M. The largest seller was Wells Fargo, cutting an estimated $21.6M.

  • 114 institutional investors held NxStage Medical Inc. (NXTM) as of Q4 2013, down from 115 in Q3 2013.
  • Funds reported $541M of NxStage Medical Inc. stock for Q4 2013, down 23% quarter-over-quarter.
  • 19 funds opened new NxStage Medical Inc. positions in Q4 2013 and 20 closed out, a net change of -1 holder.
  • The largest NxStage Medical Inc. buyer in Q4 2013 was Oracle Investment Management, an estimated $10.8M added.
  • The largest NxStage Medical Inc. seller in Q4 2013 was Wells Fargo, an estimated $21.6M sold.

Based on aggregated 13F filings for Q4 2013.